Altered systemic iron metabolism in Parkinson's disease.
about
The promise of neuroprotective agents in Parkinson's diseaseIron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processesBiology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorderManganese toxicity upon overexposure.Manganese: pharmacokinetics and molecular mechanisms of brain uptake.Assessment of plasma lactoferrin in Parkinson's disease.Ferritin levels and their association with regional brain volumes in Tourette's syndrome.Serotonergic dysfunctions and abnormal iron metabolism: Relevant to mental fatigue of Parkinson disease.Alteration of iron homeostasis following chronic exposure to manganese in rats.Differential cytotoxicity of Mn(II) and Mn(III): special reference to mitochondrial [Fe-S] containing enzymesIron and Parkinson's disease.Eryptosis as a marker of Parkinson's diseaseAssessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson's disease.Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.Investigation on Abnormal Iron Metabolism and Related Inflammation in Parkinson Disease Patients with Probable RBD.The association between Mediterranean diet adherence and Parkinson's diseaseHaptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease riskThe conundrum of iron in multiple sclerosis--time for an individualised approach.Assessing of plasma levels of iron, zinc and copper in Iranian Parkinson's disease.Genetics of iron regulation and the possible role of iron in Parkinson's disease.Dietary iron intake and risk of Parkinson's disease.Alteration of serum concentrations of manganese, iron, ferritin, and transferrin receptor following exposure to welding fumes among career welders.Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson' Disease.Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative DisordersCopper(II)-induced self-oligomerization of alpha-synuclein.High doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in Parkinson's disease patients.Neurobehavioural deficits following postnatal iron overload: II Instrumental learning performance.Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain.Serum iron, vitamin B12 and folic acid levels in Parkinson's disease.Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease.Blood donations, iron stores, and risk of Parkinson's disease
P2860
Q21129436-009157CD-940A-4173-88BE-3E330D9E722CQ22337213-6C55DB2B-35F2-4C14-A52B-967420F3B05FQ28392275-D2B4DED6-5CBD-4D60-AE09-ACD100827E33Q30979177-85734F29-1414-48FE-AA49-739225E7207AQ31088579-C2681443-DDE8-4B6D-996A-2F00BE120586Q32052230-DD02A83E-4447-4F31-83EE-8D586073DB38Q33248637-2916F2EA-6762-4CF6-A5F4-21C9B9B950DBQ33685035-34D9130D-E769-4BB6-85E2-9A38569732BCQ33865538-08AC8DEA-82F3-4002-9903-6E930C351354Q34018864-DE1F8392-8349-4C01-9105-252EDB4890C5Q34529356-C88EB4CA-55FF-4BD2-A56D-AD85EC0CDD2FQ34585744-E432394F-7401-4570-AAB2-F82EB1067670Q35067943-F7B21076-2311-4DC9-B55D-AC0D00BF915FQ35754469-FE3E95CD-8069-42DA-9716-B4DFEBF619C2Q35796988-FFE59688-DB42-4838-BBC6-254B917672CDQ35951607-6DCB72BF-F425-41D9-B69A-2FA183F3CF38Q36011968-C71A7C10-462D-44F9-8342-500CD289D3EBQ36110218-88F81A38-1AAA-4CAC-9FA6-493C27ED1F29Q36750001-3A19AB72-F450-48FE-B0CC-7AA0127C9243Q36815145-5A795E2A-B62F-4B33-A440-7C1A5818CAE9Q37305887-626B5804-2F53-41A8-B83F-CC3E6F404B48Q37727979-52D3E99F-075A-4E72-A238-26273A125B97Q37729558-E1FBE751-95B9-44D5-B4A6-36A18570A4B1Q38074340-DA14C393-1929-4DB1-AA82-E9DAB24CE064Q41475139-5D053274-B26E-498B-ADE6-CA4D0BEB63FFQ42158800-AD112DEB-346A-4ABF-8EFA-B5F1D114A192Q44591707-51A6A2E7-0FFA-445B-B2DE-CB0361A4741DQ44662745-398EDED1-33C2-49ED-9F6A-1AE3D5EED8F6Q47947787-BFE58BB5-116D-4A8C-ACE0-12E2A8C7E879Q48394128-5A1460F4-7F65-4DC8-9769-759C408148F2Q51357220-20046DDE-0633-4A09-90AC-AF15FD08E3B8Q52093058-7F7B4E11-33F8-49D4-8E62-FC93AC28903BQ57127544-63E015F5-7CB1-4476-A6F1-D97C05AC276E
P2860
Altered systemic iron metabolism in Parkinson's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Altered systemic iron metabolism in Parkinson's disease.
@en
Altered systemic iron metabolism in Parkinson's disease.
@nl
type
label
Altered systemic iron metabolism in Parkinson's disease.
@en
Altered systemic iron metabolism in Parkinson's disease.
@nl
prefLabel
Altered systemic iron metabolism in Parkinson's disease.
@en
Altered systemic iron metabolism in Parkinson's disease.
@nl
P2093
P356
P1433
P1476
Altered systemic iron metabolism in Parkinson's disease.
@en
P2093
Graziano J
LoIacono N
Logroscino G
Slavkovich V
P304
P356
10.1212/WNL.49.3.714
P407
P577
1997-09-01T00:00:00Z